Related Experiment Video
Updated: Jul 8, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
333
Long noncoding RNA polymorphisms in gynecological cancers.
Esmat Abdi1, Saeid Latifi-Navid1, Alireza Panahi1
1Department of Biology, Faculty of Sciences, University of Mohaghegh Ardabili, Ardabil, 5619911367, Iran.
Personalized Medicine
|December 14, 2023
Summary
Long noncoding RNA (lncRNA) polymorphisms show promise for predicting gynecological cancer risk and guiding personalized treatments. Further research is needed to confirm these findings across diverse populations.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Gynecological malignancies contribute significantly to cancer mortality.
- Current treatments for these cancers remain insufficient despite therapeutic advances.
- Long noncoding RNAs (lncRNAs) play crucial roles in cellular processes like differentiation, proliferation, and apoptosis, and their dysregulation is linked to tumorigenesis.
Purpose of the Study:
- To comprehensively review the impact of lncRNA polymorphisms on gynecological cancers.
- To explore the potential of lncRNA variants in cancer risk assessment and early diagnosis.
- To evaluate the role of lncRNA polymorphisms in developing personalized therapeutic strategies for gynecological malignancies.
Main Methods:
- Literature review of studies investigating lncRNA polymorphisms in gynecological cancers.
- Analysis of how single nucleotide polymorphisms (SNPs) affect lncRNA function and expression.
- Synthesis of evidence regarding the predictive value of lncRNA variants for cancer risk and treatment.
Main Results:
- lncRNA polymorphisms can influence lncRNA expression and function, contributing to cancer development.
- Specific lncRNA variants show potential as biomarkers for predicting cancer risk.
- These genetic variations may offer avenues for early detection and tailored therapies in gynecological oncology.
Conclusions:
- lncRNA polymorphisms are implicated in the development and progression of gynecological cancers.
- lncRNA-related variants hold promise for improving cancer incidence evaluation, early detection, and personalized management.
- Further extensive studies are necessary to validate these findings in larger, diverse ethnic cohorts.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
03:18Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
01:05Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
01:32RNA Splicing
56.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.4K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:57piRNA - Piwi-interacting RNAs
6.9K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K